Ginkgo-24 120 mg

Ginkgo-24 120 mg

Source Naturals4.6 (291 ratings)
Format:Tablet Quantity: 120 Tablet(s) · 120 servings
Goals
$26.55 $0.22 per serving

Product analysis

56 out of 100

Ginkgo-24 120 mg is aimed at attention and cognitive support, but its everyday benefit remains uncertain. The extract details do not establish a match with the preparations linked to favorable results.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality40

The named ginkgo markers identify parts of the extract, but its full composition is unclear. Its form quality cannot be judged confidently from those details.

Ingredient Transparency80

The ingredient amounts and named forms are disclosed. Missing mixture proportions still leave important details unclear.

Value For Money40

The ginkgo contribution cannot be compared confidently for value. The stated amount and named markers alone do not establish a worthwhile purchase.

Customer Satisfaction73

Customer feedback is positive, though the number of ratings is relatively limited. Ratings reflect satisfaction and cannot establish effectiveness or safety.

Product Focus58

The formula centers on ginkgo’s possible attention and cognitive effects. Mixed findings and differences between extracts limit confidence in an everyday benefit.

Format
Tablet
Container
120 Tablet(s)
Per serving
$0.22
Customer rating
4.6 · 291 ratings
Report analysis

Goals

Mental Focus
Impact
Moderate effect
A Ingredient FitD- PathwaysC EvidenceA+ Formulation Logic
Study evidence
Ginkgo Supportive 28 studies
Cognitive Support
Impact
Moderate effect
A Ingredient FitD- PathwaysF EvidenceA+ Formulation Logic
Study evidence
Ginkgo Supportive 87 studies
Impact
Moderate effect
B- Ingredient FitD- PathwaysC EvidenceA+ Formulation Logic
Study evidence
Ginkgo Supportive 11 studies
Brain Health
Impact
Moderate effect
A Ingredient FitD- PathwaysC- EvidenceA+ Formulation Logic
Study evidence
Ginkgo Supportive 90 studies
Productivity Boost
Impact
Moderate effect
A Ingredient FitF PathwaysD+ EvidenceA+ Formulation Logic
Study evidence
Ginkgo Supportive 20 studies

Ingredients

IngredientAmount per servingScore
Ginkgo leaf extract (Flavone Glycosides, Terpene Lactones)
120 mg 85
Gluten Free Adults 18–50 Dairy Free Sugar Free
Report overview
B- Composition And Label DisclosureA+ Composition And Label Disclosure
Ginkgo-24 120 mg gives a disclosed amount of ginkgo, while its value for ginkgo remains unclear. The serving lists 120 mg of Ginkgo Leaf Extract. It lists 24% flavones and 6% terpenes. No ginkgolic acid upper limit is stated in the available information.
How this ingredient is rated

Composition and Label Disclosure70

It lists 24% flavones and 6% terpenes. No ginkgolic acid upper limit is stated in the available information.
Marker and Preparation Disclosure
It lists 24% flavones and 6% terpenes.
Declared Ginkgolic Acid Limit
No ginkgolic acid upper limit is stated in the available information.

Composition and Label Disclosure100

The serving lists 120 mg of Ginkgo Leaf Extract.
Individual Preparation Amount Disclosure
The serving lists 120 mg of Ginkgo Leaf Extract.

Commercial Price and Usability

Value for ginkgo has not been established.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  2. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health Cognitive Support forGinkgo
  3. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  4. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  5. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  6. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  7. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support forGinkgo
  8. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  9. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  10. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsEye Health forGinkgo
  11. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E · Ophthalmology · 2003
    Randomized trial27 participantsEye Health forGinkgo
  12. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsEye Health forGinkgo
  13. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
    Park JW; Kwon HJ; Chung WS; Kim CY; Seong GJ · Korean journal of ophthalmology : KJO · 2012
    Randomized trial30 participantsEye Health forGinkgo
  14. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
    Lanthony P; Cosson JP · Journal francais d'ophtalmologie · 1989
    Randomized trial29 participantsEye Health forGinkgo
  15. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  16. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  17. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  18. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  19. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  20. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo